3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Classical hematology
2
Conditions
Neoplasms
4
Venous Thrombosis
2
Venous Thromboembolism
2
Pulmonary Embolism
2
Thrombosis
1
Prostatic Neoplasms
1
Myeloproliferative Disorders
1
Multiple Endocrine Neoplasia Type 1
1
Hot Flashes
1
Cushing Syndrome
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Advanced Non-small Cell Lung Cancer
1
Interventions
apixaban
11
Dalteparin
10
Rivaroxaban
7
Enoxaparin
5
Fondaparinux
4
Tinzaparin
3
Heparin, Low-Molecular-Weight
3
Aspirin
3
edoxaban
2
Warfarin
2
Observation
2
Dabigatran
2
sotorasib
1
calcium heparin
1
betrixaban
1
bemiparin
1
argatroban
1
Tacrolimus
1
Tablets
1
Simvastatin
1
Rosuvastatin Calcium
1
Nadroparin
1
Heparin
1
Gemcitabine
1
Drug Therapy
1
Data Collection
1
Cyclosporine
1
AVE 5026
1
ALT-836
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Venous Thromboembolism
×
Dabigatran
×
Clear all
NCT02744092
2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA
Completed
811 enrolled
19 charts
NCT03965741
2021-11-30
PRACTISE
Bayer
Completed
97,765 enrolled